FOR REMOTE PATIENT MONITORING

RESP® Biosensor

Enhance your patient monitoring capabilities from hospital to home

FDA 510(k) Class II | CE Mark | HIPAA Compliant

cough monitoring RESP biosensor

Technology Overview

The RESP® Biosensor offers clinicians and healthcare teams a first-of-its-kind technology to advance respiratory disease surveillance and management.

  • Continuous and passive lung sound monitoring to extend the range of stethoscope auscultation and in-person assessments¹
  • Patient-friendly form factor that respects patient comfort and lifestyle.
  • Physiological data including heart rate*, heart rate variability*, and respiratory rate*

*Measurement not yet FDA cleared

1. Equivalent performance to 3M Littman 3200 Electronic Stethoscope (source)

Strados Cough Monitoring Solution

OVERVIEW VIDEO

“With this information we can predict if the patient is doing better or worse and intervene ahead of time to prevent the patient from having major complications”

– Sadia Benzaquen, MD, Chair of Pulmonary Critical Care, Einstein Medical Center

Track Patient Progress Objectively and Remotely

Patient reports include accurate, time-stamped data on signs and symptoms such as coughing and wheezing, allowing for greater diagnostics and insight into treatment response.

KEY FEATURES

  • Passive & continuous
  • Notifications for clinical deterioration
  • HIPAA compliant
  • Reimbursable under RTM & RPM codes
  • 24+ hour battery life & rechargeable
  • EHR/telehealth integration
  • Flexible reporting of lung sounds including automated* and manual options

*Machine learning algorithms not FDA cleared

Lung sound recordings captured by the biosensor are depicted visually as spectrograms

Cough

Wheeze

Crackles

Interested in a Research Collaboration?

We’re seeking clinical and academic collaborators to explore how wearable respiratory technologies can improve patient outcomes. Partners may be eligible for in-kind support.

RESP® Biosensor Care Settings

Ambulatory Care

 

  • Remote monitoring of at-risk COPD & Asthma patients
  • Interstitial lung diseases
  • Heart failure
  • Pulmonary Rehabilitation

Acute Care

 

  • In-patient status monitoring
  • Chronic, complex care management
  • Hospital at Home
  • Tele-ICUs

Post-Acute Care

 

  • Post-discharge hospital to home
  • Post-surgical recovery and rehabilitation
  • Skilled-nursing and long-term care facilities

Practice Application

At-risk COPD patient is discharged from hospital

Patient is prescribed RESP®  Biosensor for two weeks

On day 5, clinician receives  alert of increased coughing and wheezing

Clinician checks in with patient virtually and adjusts treatment plan to avoid a readmission

Publications

View our clinical validation, whitepapers and case studies

Stepwise Validation Program

Increasing Abnormal Lung Sounds After Discharge Predicts COPD Readmission

Poster Presentation, CHEST, 2023

Objective Cough Monitoring

Remote Auscultation At Home After Asthma Exacerbation: A Case from Discharge to Readmission

Poster Presentation, American Thoracic Society, 2020

Results of Clinical performance testing in Chronic lung diseases
Results of Clinical Performance Testing in Chronic Lung Diseases

Poster Presentation, American Thoracic Society, 2022

Talk to our Team

Reach out to explore using the RESP Biosensor in your practice